Urology

ABU: Life-long learning will be relevant, less burdensome"The ABU is committed to evolving a [life-long learning] program that diplomates find relevant and less burdensome. We will always welcome diplomates’ feedback regarding this evolving program," writes H. Ballentine Carter, MD.
Genomic testing linked to higher surveillance uptakeIn men with clinically low-risk prostate cancer managed in community-based urology practices, utilization of active surveillance as initial management is higher among those who undergo genomic testing.
Foot stimulation may offer home-based OAB treatmentNew research may pave the way for a form of nerve stimulation for refractory overactive bladder that is home based and less invasive than current neuromodulation approaches.
Are you taking steps to prevent data breaches?"Urologists need to be ever more vigilant to protect the private information under their custodianship," writes Robert A. Dowling, MD.
Repeat hydrodistention found safe in treating ICRepeated hydrodistention as therapy for interstitial cystitis has a low complication rate and does not decrease bladder capacity over time.
Immediate post-TURBT mitomycin instillation reduces recurrence riskMitomycin C instillation within 24 hours after transurethral resection of non-muscle invasive bladder cancer significantly reduces the risk of recurrence and delays the time to recurrence.
IC/BPS: One-fourth of patients have Hunner lesionsAbout one-fourth of patients with interstitial cystitis/bladder pain syndrome have Hunner lesions in the bladder visible on cystoscopy.
How to reduce opioid use in post-op patientsIn this interview, urologist Francis J. McGovern, MD, discusses the scope of the problem of opioid abuse, outlines opioid-sparing strategies, and explains what the future holds in this area.
How to choose between Roth, traditional accounts
SNS vs. botulinum: Caveats, considerations